{"data":{"id":"us-al/ala.-code-22-5d-5","jurisdiction":"us-al","citation":"Ala. Code § 22-5D-5","heading":"Liability of Heirs.","body":"If a patient dies while being treated by an investigational drug, biological product, or device, the patient’s heirs are not liable for any outstanding debt related to the treatment or lack of insurance due to the treatment.","path":["Title 22 Health, Mental Health, and Environmental Control.","Title 1 Health and Environmental Control Generally.","Chapter 5D Gabe Griffin Right to Try Act."],"source_url":"https://alison.legislature.state.al.us/code-of-alabama?section=22-5D-5","current_through":"Act 2026-611","vintage":"","retrieved_at":"2026-09-03T14:01:53Z","sha256":"f7952cdc3015aac42900d91a2e2bf8f2daf633736be225d98802543e9f1af61f","source_id":"us-al","stale":false,"prev":"us-al/ala.-code-22-5d-4","next":"us-al/ala.-code-22-5d-6"},"notice":"GroundRules: Original legal text. Not legal advice."}